Analysis reveals shifting dengue virus serotype prevalence from 2013 to 2024 at Rawalpindi Medical University, highlighting implications for public health responses.
Key Points
DENV-2 was the predominant serotype, peaking at 72% in 2017, and revealing trends in dengue dynamics.
Significant shifts included DENV-3 emergence in 2014 and DENV-1 dominating at 71% by 2023, indicating fluctuating patterns.
Statistical analysis showed DENV-2's dominance was significant (p = 0.018), with implications for disease severity and public health.
Continuous monitoring of serotype trends is crucial to inform prevention strategies against potential outbreaks.